NDC 76282-208-01 - CITALOPRAM HYDROBROMIDE

This NDC is not currently matched to an FDA NDC product listing in FDA.report, but it is a valid NDC-form code. FDA.report is showing the available DailyMed label context for the product root.

Product NDC: 76282-208
Requested NDC: 76282-208-01
Package NDCs from labels: 76282-208-30, 76282-208-90, 76282-208-05, 76282-208-10, 76282-208-01
Manufacturer: Aphena Pharma Solutions - Tennessee, LLC
Effective date: 2026-03-04
Current FDA listing: Not matched in FDA.report NDC product tables

DailyMed Labels#

Label, Manufacturer, Effective date table
Label	Manufacturer	Effective date	Type
CITALOPRAM HYDROBROMIDE - Aphena Pharma Solutions - Tennessee, LLC	Aphena Pharma Solutions - Tennessee, LLC	2026-03-04	HUMAN PRESCRIPTION DRUG LABEL
CITALOPRAM - Exelan Pharmaceuticals Inc. \| InvaGen Pharmaceuticals Inc.	Exelan Pharmaceuticals Inc. \| InvaGen Pharmaceuticals Inc.	2024-08-01	HUMAN PRESCRIPTION DRUG LABEL
National Council for Prescription Drug Programs indexing - billing unit	National Council for Prescription Drug Programs	2013-02-13	Indexing - Billing Unit

DailyMed Package Descriptions#

Package NDC, Product, Description table
Package NDC	Product	Description	Form	Quantity	SPL version
76282-208-05	CITALOPRAM HYDROBROMIDE	500 in 1 BOTTLE	TABLET	500	15
76282-208-10	CITALOPRAM HYDROBROMIDE	1000 in 1 BOTTLE	TABLET	1000	15
76282-208-30	CITALOPRAM HYDROBROMIDE	30 in 1 BOTTLE	TABLET	30	15
76282-208-90	CITALOPRAM HYDROBROMIDE	90 in 1 BOTTLE	TABLET	90	15

DailyMed Dashboard NDC Coverage#

NDC, Dashboard title, SPL version table
NDC	Dashboard title	SPL version	Validation	Dashboard ZIP
76282-208	CITALOPRAM HYDROBROMIDE (CITALOPRAM ) TABLET [EXELAN PHARMACEUTICALS INC.]	15	Current NDC, Legacy NDC, 4 package rows	20240912_a8e8fde2-8392-4d5b-902b-e2b9dd55a02d.zip

DailyMed Billing Units#

Package NDC, Billing unit, Product NDC table
Package NDC	Billing unit	Product NDC	DailyMed indexing SPL	SPL version	Effective
76282-208-01	EA - Each	76282-208	2f395c5a-7bf1-4b00-9b6d-09bb7957a7c7	1	2013-02-13
76282-208-05	EA - Each	76282-208	9bd5dca2-1b6b-4070-9fe8-be1eb7aec31c	1	2013-02-13
76282-208-10	EA - Each	76282-208	c7681eb7-5aa6-4582-9cfd-fc7b0c186098	1	2013-02-13
76282-208-30	EA - Each	76282-208	68c2e058-4593-4b8a-afca-6e766e300dcc	1	2013-02-13
76282-208-90	EA - Each	76282-208	be2d5169-e537-4b61-bcbd-ebf40beac752	1	2017-09-11

DailyMed Socrata Ingredients#

Ingredient, Type, UNII table
Ingredient	Type	UNII	DailyMed label	SPL version
CITALOPRAM HYDROBROMIDE	ACTIVE INGREDIENT	I1E9D14F36	CITALOPRAM HYDROBROMIDE (CITALOPRAM ) TABLET [EXELAN PHARMACEUTICALS INC.]	2
CITALOPRAM	ACTIVE MOIETY	0DHU5B8D6V	CITALOPRAM HYDROBROMIDE (CITALOPRAM ) TABLET [EXELAN PHARMACEUTICALS INC.]	2
CELLULOSE, MICROCRYSTALLINE	INACTIVE INGREDIENT	OP1R32D61U	CITALOPRAM HYDROBROMIDE (CITALOPRAM ) TABLET [EXELAN PHARMACEUTICALS INC.]	2
COPOVIDONE	INACTIVE INGREDIENT	D9C330MD8B	CITALOPRAM HYDROBROMIDE (CITALOPRAM ) TABLET [EXELAN PHARMACEUTICALS INC.]	2
CROSCARMELLOSE SODIUM	INACTIVE INGREDIENT	M28OL1HH48	CITALOPRAM HYDROBROMIDE (CITALOPRAM ) TABLET [EXELAN PHARMACEUTICALS INC.]	2
LACTOSE MONOHYDRATE	INACTIVE INGREDIENT	EWQ57Q8I5X	CITALOPRAM HYDROBROMIDE (CITALOPRAM ) TABLET [EXELAN PHARMACEUTICALS INC.]	2
MAGNESIUM STEARATE	INACTIVE INGREDIENT	70097M6I30	CITALOPRAM HYDROBROMIDE (CITALOPRAM ) TABLET [EXELAN PHARMACEUTICALS INC.]	2

openFDA label cross-check#

OpenFDA label data provides additional search and identifier links. DailyMed’s Structured Product Label is the canonical label on FDA.report. Matching records are deduplicated before they are shown below.

Matched openFDA labels page 111 of 113 · 2,248 matching rows.

Brand, Generic, Manufacturer table
Brand	Generic	Manufacturer	SPL set ID	Effective date	Available safety fields	Join
No7 Perfect and Perfect Intense Advanced All in One Foundation SPF 50 Creme	OCTINOXATE, TITANIUM DIOIXIDE, OCTISALATE	BCM Cosmetique SAS	753c34f2-3cb8-4df7-9aeb-ea926fb0279a	2021-06-29	Warnings	Exact identifier unii: 15FIX9V2JP
No7 Perfect and Perfect Intense Advanced All in One Foundation SPF 50 Dune	OCTINOXATE, TITANIUM DIOIXIDE, OCTISALATE	BCM Cosmetique SAS	745dd675-86ee-4acc-8333-4870e0a57c75	2021-06-29	Warnings	Exact identifier unii: 15FIX9V2JP
No7 Perfect and Perfect Intense Advanced All in One Foundation SPF 50 Latte	OCTINOXATE, TITANIUM DIOIXIDE, OCTISALATE	BCM Cosmetique SAS	e66734e4-34e7-4674-bb98-bdca931a176d	2021-06-29	Warnings	Exact identifier unii: 15FIX9V2JP
No7 Perfect and Perfect Intense Advanced All in One Foundation SPF 50 Sand	OCTINOXATE, TITANIUM DIOIXIDE, OCTISALATE	BCM Cosmetique SAS	bf78f7a7-93ca-425e-8571-175da6798e8e	2021-06-29	Warnings	Exact identifier unii: 15FIX9V2JP
No7 Perfect and Perfect Intense Advanced All in One Foundation SPF 50 Sepia	OCTINOXATE, TITANIUM DIOIXIDE, OCTISALATE	BCM Cosmetique SAS	418cdd4a-23f7-4181-b734-5ab7456494a2	2021-06-29	Warnings	Exact identifier unii: 15FIX9V2JP
No7 Perfect and Perfect Intense Advanced All in One Foundation SPF 50 Toffee	OCTINOXATE, TITANIUM DIOIXIDE, OCTISALATE	BCM Cosmetique SAS	50138c51-f424-4b07-b3eb-c0d31d8ecf16	2021-06-29	Warnings	Exact identifier unii: 15FIX9V2JP
No7 Protect and Perfect Intense Advanced All in One Foundation SPF 50 Cameo	OCTINOXATE, TITANIUM DIOIXIDE, OCTISALATE	BCM Cosmetique SAS	01a861b9-0ab6-4c4c-a407-428a64509a1c	2021-06-29	Warnings	Exact identifier unii: 15FIX9V2JP
No7 Protect and Perfect Intense Advanced All in One Foundation SPF 50 Birch	OCTINOXATE, TITANIUM DIOIXIDE, OCTISALATE	BCM Cosmetique SAS	d5431d62-fded-4cdc-81a1-5b5e3eb92873	2021-06-29	Warnings	Exact identifier unii: 15FIX9V2JP
No7 Protect and Perfect Intense Advanced All in One Foundation SPF 50 Tawny	OCTINOXATE, TITANIUM DIOIXIDE, OCTISALATE	BCM Cosmetique SAS	52c3378f-6b99-42fa-900e-8a693864c615	2021-06-29	Warnings	Exact identifier unii: 15FIX9V2JP
Citalopram	CITALOPRAM	Aphena Pharma Solutions - Tennessee, LLC	3d70380f-ef97-4de9-a8f8-44ef9ba7e5a7	2020-05-13	Boxed warning, Warnings, Adverse reactions	Exact identifier rxcui: 309314 unii: I1E9D14F36
Citalopram	CITALOPRAM HYDROBROMIDE	Aphena Pharma Solutions - Tennessee, LLC	31ddd184-7560-473c-b674-5fa3187c5598	2020-04-24	Boxed warning, Warnings, Adverse reactions	Exact identifier rxcui: 309314 unii: I1E9D14F36
Citalopram	CITALOPRAM	Aphena Pharma Solutions - Tennessee, LLC	0867140e-a483-4bf7-8326-4a9730cc9d9d	2020-04-22	Boxed warning, Warnings, Adverse reactions	Exact identifier application number: ANDA077534 rxcui: 309314 unii: I1E9D14F36
Citalopram	CITALOPRAM HYDROBROMIDE	Proficient Rx LP	289c1d5e-902f-47db-85b8-5e1a55ec8684	2019-11-01	Boxed warning, Warnings, Adverse reactions	Exact identifier rxcui: 200371 unii: I1E9D14F36
No7 Perfect and Perfect Intense Advanced All in One Foundation SPF 50 Cool Vanilla	OCTINOXATE, TITANIUM DIOIXIDE, OCTISALATE	BCM Cosmetique SAS	d701c221-9f68-47ff-b766-2f4f1998649f	2019-10-08	Warnings	Exact identifier unii: 15FIX9V2JP
No7 Perfect and Perfect Intense Advanced All in One Foundation SPF 50 Amber	OCTINOXATE, TITANIUM DIOIXIDE, OCTISALATE	BCM Cosmetique SAS	7f5e6872-4d26-410e-8afe-16a016f9a399	2019-10-08	Warnings	Exact identifier unii: 15FIX9V2JP
No7 Perfect and Perfect Advanced All in One Foundation SPF 50 Warm Ivory	OCTINOXATE, TITANIUM DIOIXIDE, OCTISALATE	BCM Cosmetique SAS	1124ba7d-a328-409b-8c88-e74bb3e501f5	2019-10-08	Warnings	Exact identifier unii: 15FIX9V2JP
No7 Perfect and Perfect Advanced All in One Foundation SPF 50 Honey	OCTINOXATE, TITANIUM DIOIXIDE, OCTISALATE	BCM Cosmetique SAS	9c407dc7-fcde-4660-9a06-57bd8a6b867d	2019-10-08	Warnings	Exact identifier unii: 15FIX9V2JP
No7 Perfect and Perfect Intense Advanced All in One Foundation SPF 50 Chestnut	OCTINOXATE, TITANIUM DIOIXIDE, OCTISALATE	BCM Cosmetique SAS	f07e8bb2-30ae-4337-ad60-84f55f2ff354	2019-10-08	Warnings	Exact identifier unii: 15FIX9V2JP
CLE CCC Golden Medium Deep	TITANIUM DIOXIDE, OCTINOXATE, OCTISALATE	KW ABSC, INC.	b7a4847f-b84d-4f36-8787-104eccd838a0	2018-12-03	Warnings	Exact identifier unii: 15FIX9V2JP
CLE CCC Warm Medium Deep	TITANIUM DIOXIDE, OCTINOXATE, OCTISALATE	KW ABSC, INC.	229c20a3-6288-4ac3-9098-6d1622e906ab	2018-11-29	Warnings	Exact identifier unii: 15FIX9V2JP

Reported adverse events (FAERS/openFDA)#

Adverse event summaries are temporarily unavailable. Other product information remains available.